CAMBRIDGE, Mass. (AP) _ Genocea Biosciences Inc. (GNCA) on Thursday reported a loss of $4.4 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 5 cents. Losses, adjusted for non-recurring gains, were 11 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The company's shares closed at 63 cents. A year ago, they were trading at $5.64.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GNCA at